| __timestamp | GSK plc | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 7323000000 | 117418000 |
| Thursday, January 1, 2015 | 8853000000 | 102526000 |
| Friday, January 1, 2016 | 9290000000 | 105386000 |
| Sunday, January 1, 2017 | 10342000000 | 110188000 |
| Monday, January 1, 2018 | 10241000000 | 121544000 |
| Tuesday, January 1, 2019 | 11863000000 | 127930000 |
| Wednesday, January 1, 2020 | 11704000000 | 148917000 |
| Friday, January 1, 2021 | 11603000000 | 440760000 |
| Saturday, January 1, 2022 | 9554000000 | 540517000 |
| Sunday, January 1, 2023 | 8565000000 | 435577000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue for GSK plc and Jazz Pharmaceuticals plc from 2014 to 2023. Over this period, GSK plc consistently reported a higher cost of revenue, peaking in 2019 with a 62% increase from 2014. In contrast, Jazz Pharmaceuticals plc maintained a more modest cost structure, with a notable spike in 2022, reaching 360% of its 2014 cost. This disparity highlights GSK's expansive operations compared to Jazz's more focused approach. The data suggests that while GSK's scale offers potential for greater market reach, Jazz's leaner cost structure may provide agility in a competitive landscape. As the industry faces new challenges, understanding these dynamics is crucial for stakeholders aiming to optimize financial performance.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Jazz Pharmaceuticals plc
GSK plc vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for GSK plc and ADMA Biologics, Inc.
Cost of Revenue Comparison: GSK plc vs CRISPR Therapeutics AG
Cost of Revenue: Key Insights for GSK plc and Galapagos NV
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Alkermes plc
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored